Nanophase Technologies Corp ( (SLSN) ) has released its Q1 earnings. Here is a breakdown of the information Nanophase Technologies Corp presented to its investors.
Solésence, Inc., a leader in scientifically-driven healthcare solutions across beauty and life science categories, focuses on delivering innovative mineral-based sun protection and skin health products. The company recently reported a record first-quarter revenue of $14.6 million, marking a 48% increase from the previous year, driven by strong sales and new brand partnerships. Despite achieving record revenue and shipment volumes, Solésence experienced a decrease in gross profit margins due to one-time start-up costs associated with a new product launch. The company also celebrated its uplisting to Nasdaq, enhancing its visibility in the financial community. Looking ahead, Solésence anticipates continued revenue growth and improved gross margins as it scales operations and manages costs more efficiently, aiming to drive long-term shareholder value.